Seres Therapeutics, Inc. Business Operations Contracts & Agreements
17 Contracts & Agreements
- Advisory Agreements (2 contracts)
- Agency Agreements (1)
- Collaboration Agreements (3)
- Indemnification Agreements (2)
- Sales Agreements (3)
- Supply Agreements (3)
- Termination Agreements (3)
- Mutual Termination of Collaboration and License Agreement dated September 30, 2024, by and between Seres Therapeutics, Inc. and Société des Produits Nestlé S.A (Filed With SEC on November 13, 2024)
- Mutual Termination of License Agreement dated September 30, 2024, by and between Seres Therapeutics, Inc. and NHSc Rx License GmbH (Filed With SEC on November 13, 2024)
- Assignment and Termination of Manufacturing Agreement, dated August 5, 2024, by and between Seres and Bacthera AG (Filed With SEC on August 13, 2024)
- Supply Agreement, dated September 15, 2015, by and between the Registrant and GenIbet BioPharmaceuticals, SA, as amended (Filed With SEC on May 8, 2024)
- Advisory Agreement, dated March 15, 2024, by and between the Registrant and David Arkowitz (Filed With SEC on May 8, 2024)
- Supply Agreement, dated September 15, 2015, by and between Registrant and GenIbet BioPharmaceuticals, SA, as amended (Filed With SEC on March 5, 2024)
- Supply Agreement, dated September 15, 2015, by and between Seres Therapeutics, Inc. and GenIbet BioPharmaceuticals, SA, as amended (Filed With SEC on November 2, 2022)
- Placement Agency Agreement, dated June 29, 2022, by and between Seres Therapeutics, Inc. and J.P. Morgan Securities LLC (Filed With SEC on June 30, 2022)
- Sales Agreement, dated as of May 21, 2021, between Seres Therapeutics, Inc. and Cowen and Company, LLC (Filed With SEC on May 21, 2021)
- Sales Agreement, dated as of March 18, 2020, between Seres Therapeutics, Inc. and Cowen and Company, LLC (Filed With SEC on March 18, 2020)
- Advisory Agreement, dated December 12, 2019, by and between the Registrant and Roger Pomerantz (Filed With SEC on March 2, 2020)
- Sales Agreement, dated as of November 27, 2019, between Seres Therapeutics, Inc. and Cowen and Company, LLC (Filed With SEC on November 27, 2019)
- Research Collaboration and Option Agreement, dated March 11, 2019, by and between the Registrant and MedImmune, LLC (Filed With SEC on May 2, 2019)
- Amendment No 1 to the Collaboration and License Agreement, dated August 10, 2016, by and between the Registrant and Nestec Ltd (Filed With SEC on March 6, 2019)
- COLLABORATION AND LICENSE AGREEMENT between NESTEC LTD. and SERES THERAPEUTICS, INC. (Filed With SEC on May 16, 2016)
- SERES THERAPEUTICS, INC. INDEMNIFICATION AGREEMENT (Filed With SEC on June 16, 2015)
- FORM OF INDEMNIFICATION AGREEMENT (Filed With SEC on May 27, 2015)
